Cerebrovascular Effects of Prostaglandin Inhibitors in the Gerbil
Author(s) -
Alan Crockard,
Fausto Iannotti,
Graeme Ladds
Publication year - 1982
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.1982.7
Subject(s) - gerbil , autoregulation , prostaglandin , chemistry , cerebral blood flow , thromboxane , cerebral autoregulation , thromboxane a2 , medicine , endocrinology , pharmacology , blood pressure , anesthesia , biochemistry , receptor , platelet , ischemia
Autoregulation of cerebral blood flow (CBF) to mean arterial blood pressure (MABP) of 40–50 mm Hg has been demonstrated in the spontaneously breathing gerbil anaesthetised with barbiturate (60 mg/kg). CO 2 reactivity has also been assessed at 2.8% change CBF/mm Hg change in arterial Pco 2 In six animals pretreated with indomethacin (3 mg/kg), autoregulation was preserved although the resting CBF was significantly reduced, but CO 2 reactivity was completely abolished. 1- n-Butyl imidazole, a specific thromboxane synthetase inhibitor, was used in six other animals (3 mg/kg), and this abolished CO 2 reactivity while preserving autoregulation; the effect of this agent has not been described previously. Both drugs inhibit different pathways of prostaglandin metabolism and may interfere with normal CO 2 reactivity in several ways. Two explanations are that prostaglandins constitute the final common pathway in effecting cerebrovascular response to CO 2 or, alternatively, that the free radicals and ionic fluxes generated during prostaglandin metabolism are a coincidental source of the hydrogen ion changes required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom